Data through close

Net delta positioning extremes

Which liquid chains had the strongest positive and negative delta-weighted positioning on Oct 15, 2026?

Aggregate option-holder delta divided by 100 shares times total open interest. The 25 most positive observations appear first, followed by the 25 most negative. Data through close. Descriptive only, not a recommendation.

At a glance

50 tickers qualified. First five: AVTR (0.747), PBR.A (0.696), VTRS (0.597), NNDM (0.573), XP (0.513).

Net delta positioning extremes as of Oct 15, 2026 close
# Ticker Close Open interest Normalized net delta
1 AVTR 16.09 134,292 0.747
2 PBR.A 22.61 219,841 0.696
3 VTRS 18.22 124,166 0.597
4 NNDM 1.44 135,739 0.573
5 XP 30.04 1,196,952 0.513
6 CRON 3.20 105,318 0.508
7 CORN 18.35 133,064 0.499
8 PGEN 7.20 113,750 0.499
9 CHGG 0.76 126,928 0.484
10 HLF 14.57 138,549 0.469
11 INO 1.04 117,792 0.467
12 SG 10.60 272,925 0.457
13 CODI 10.62 259,436 0.455
14 CNC 70.51 237,424 0.431
15 BMBL 5.93 105,812 0.422
16 PACB 1.96 193,294 0.418
17 QSI 1.31 108,213 0.405
18 NAK 0.92 232,745 0.405
19 BNO 64.86 313,696 0.399
20 IBRX 10.00 699,220 0.398
21 OSCR 33.47 450,320 0.398
22 UPXI 1.06 160,644 0.392
23 GME 28.02 2,025,839 0.387
24 ETSY 89.18 177,407 0.381
25 DLO 15.10 239,419 0.379
26 ARDX 3.27 230,253 -0.383
27 UAA 4.88 503,952 -0.317
28 ABR 2.80 202,026 -0.273
29 CG 36.81 114,710 -0.250
30 KKR 87.63 285,653 -0.240
31 BX 109.26 515,414 -0.204
32 OWL 8.97 850,069 -0.187
33 SPXS 24.00 281,840 -0.172
34 KORU 12.01 386,665 -0.172
35 XE 11.45 138,386 -0.170
36 GT 4.42 181,518 -0.166
37 EWJ 95.43 111,280 -0.158
38 COHR 250.60 301,195 -0.155
39 HYG 77.13 10,838,745 -0.153
40 XEL 75.12 208,768 -0.139
41 BN 36.81 103,457 -0.137
42 AGNC 8.82 810,920 -0.137
43 VSH 28.76 107,689 -0.136
44 ASHR 31.49 577,270 -0.136
45 KBE 63.55 216,009 -0.134
46 NLY 18.43 235,231 -0.130
47 CCJ 83.23 492,336 -0.130
48 SERV 3.49 224,679 -0.129
49 LCID 3.50 912,496 -0.127
50 GRRR 8.41 147,320 -0.126

Screens describe what the data shows after the close. They are not trade recommendations; see the disclaimer and the methodology.